A role for DOT1L in MLL-rearranged leukemias

Epigenomics

Volumn 3, Issue 6, 2011, Pages 667-670

  Bernt, Kathrin M ^a,b,c   Armstrong, Scott A ^a,b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c Karp Family Research Laboratories   (United States)

Author keywords

chromatin; DOT1L; epigenetic regulation; histone code; MLL rearranged leukemias; transcriptional elongation

Indexed keywords

HISTONE METHYLTRANSFERASE; MIXED LINEAGE LEUKEMIA PROTEIN; PROTEIN DOT1L; UNCLASSIFIED DRUG;

CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; DNA SEQUENCE; EPIGENETICS; GENE EXPRESSION; GENE FUNCTION; GENE FUSION; GENE INTERACTION; GENETIC ASSOCIATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA; PRIORITY JOURNAL; REVIEW;

CHROMATIN IMMUNOPRECIPITATION; EPIGENESIS, GENETIC; GENE REARRANGEMENT; HISTONE CODE; HISTONES; HUMANS; LEUKEMIA; METHYLATION; METHYLTRANSFERASES; MYELOID-LYMPHOID LEUKEMIA PROTEIN; TRANSCRIPTION FACTORS;

EID: 82455186371     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.11.98     Document Type: Review

References (18)

1. Steger DJ, Lefterova MI, Ying L et al. DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells. Mol. Cell Biol. 28(8), 2825-2839 (2008).
2. Okada Y, Feng Q, Lin Y et al. hDOT1L links histone methylation to leukemogenesis. Cell 121(2), 167-178 (2005).
3. Bitoun E, Oliver PL, Davies KE. The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling. Hum. Mol. Genet. 16(1), 92-106 (2007).
4. Mueller D, Bach C, Zeisig D et al. A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification. Blood 110(13), 4445-4454 (2007).
5. Mueller D, Garcia-Cuellar MP, Bach C, Buhl S, Maethner E, Slany RK. Misguided transcriptional elongation causes mixed lineage leukemia. PLoS Biol. 7(11), e1000249 (2009).
6. Lin C, Smith ER, Takahashi H et al. AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia. Mol. Cell 37(3), 429-437 (2010).
7. Yokoyama A, Lin M, Naresh A, Kitabayashi I, Cleary ML. A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription. Cancer Cell 17(2), 198-212 (2010).
8. Mohan M, Herz HM, Takahashi YH et al. Linking H3K79 trimethylation to Wnt signaling through a novel Dot1-containing complex (DotCom).Genes Dev. 24(6), 574-589 (2010).
9. Muntean AG, Tan J, Sitwala K et al. The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis. Cancer Cell 17(6), 609-621 (2010).
10. Biswas D, Milne TA, Basrur V et al. Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes. Proc. Natl Acad. Sci. USA 108(38), 15751-15756 (2011).
11. Milne TA, Martin ME, Brock HW, Slany RK, Hess JL. Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications. Cancer Res. 65(24), 11367-11374 (2005).
12. Krivtsov AV, Feng Z, Lemieux ME et al. H3K79 methylation profiles define murine and human MLL-AF4 leukemias. Cancer Cell 14(5), 355-368 (2008).
13. Guenther MG, Lawton LN, Rozovskaia T et al. Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia. Genes Dev. 22(24), 3403-3408 (2008).
14. Bernt KM, Zhu N, Sinha AU et al. MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. Cancer Cell 20(1), 66-78 (2011).
15. Daigle SR, Olhava EJ, Therkelsen CA et al. Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor. Cancer Cell 20(1), 53-65 (2011).
16. Jo SY, Granowicz EM, Maillard I, Thomas D, Hess JL. Requirement for DOT1L in murine postnatal hematopoiesis and leukemogenesis by MLL translocation. Blood 117(18), 4759-4768 (2011).
17. Chang MJ, Wu H, Achille NJ et al. Histone H3 lysine 79 methyltransferase Dot1 is required for immortalization by MLL oncogenes. Cancer Res. 70(24), 10234-10242 (2010).
18. Nguyen AT, Taranova O, He J, Zhang Y. DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis. Blood 117(25), 6912-6922 (2011).